中国初级卫生保健基金会

What 中国初级卫生保健基金会 does

中国初级卫生保健基金会 (China Primary Health Care Foundation) is a 4A-rated public fundraising foundation established on December 30, 1996, and headquartered in Chaoyang District, Beijing. It is hosted by the Chinese Peasants' and Workers' Democratic Party (NPG) Central Committee, supervised by the National Health Commission, and registered with the Ministry of Civil Affairs. The foundation's mission is to address gaps in primary healthcare access, medical poverty, and grassroots capacity building across China. Its programs are organized around three core pillars: (1) patient assistance projects providing financial and medication aid for oncology, hemophilia, rare disease, and other high-cost conditions; (2) grassroots healthcare capacity building covering 3,800+ partner hospitals with equipment donations, specialty department construction, and doctor training; and (3) regional health initiatives such as the 善行边疆 border-region program and 互联网+医疗 (Internet+ Healthcare) projects.

The foundation operates a multi-program charitable platform rather than a unified technology product, with named initiatives including 同心全科医生特岗人才公益项目, 东方关爱公益项目, 携爱同行公益项目, 新燕公益项目, 爱心惠民公益项目, 蓝农公益项目 (Zhang Wenhong-led infectious disease initiative), 通用环球公益专项基金, and 首都卫生发展科研专项迈瑞联合专项. It also publishes the professional journal 中国初级卫生保健 (China Primary Health Care) — the only national-level publication dedicated to primary healthcare theory, policy, and practice.

Its business model is donation-driven: revenue is sourced from corporate donations (AstraZeneca, Merck Sharp & Dohme, Pfizer, 神州细胞工程, Mindray), individual contributions via bank transfer, WeChat QR, and postal remittance, government fiscal allocations (initial registered capital of 8 million yuan), and investment income on endowment assets. In 2024, the foundation recorded 112.91 billion CNY in welfare income and 140.87 billion CNY in expenditures; in 2025, fundraising reached 138.95 billion CNY with 139.15 billion CNY disbursed. The organization functions as an asset-light coordinator with only 22 employees, channeling ~99% of funds through its hospital and pharmacy distribution network (Sinopharm, Shanghai Pharma Yixin, JD Renkang) to underprivileged patients and under-resourced institutions. Major corporate donors receive branded 专项基金 status and CSR visibility, while patients receive direct subsidies, free medications, and surgeries in border and rural regions including Tibet, Xinjiang, Heilongjiang, Henan, and Shandong.

Name

中国初级卫生保健基金会

Legal name

中国初级卫生保健基金会

Website

https://cphcf.org.cn

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

中国初级卫生保健基金会 is a 4A-rated national public fundraising foundation established in 1996 that channels charitable donations from multinational pharmaceutical companies, medical device makers, and individuals into patient assistance programs (oncology, hemophilia, rare disease), grassroots hospital capacity building across 3,800+ facilities, and border-region health initiatives throughout China.

Ownership category

akta.pro rank

Product category

Charitable Healthcare Foundation

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Public Health Financing, Budgeting & Grants Management (HLAJAMAC)

akta.pro secondary industries

Chronic Disease & Health Promotion Program Funding (HLAJALAJ), Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Public health foundation
• Patient assistance programs
• Healthcare charity
• Primary care services
• Medical aid programs

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Public Donations and Charitable Contributions: The foundation raises donations from pharmaceutical companies, medical device corporations, healthcare enterprises, government bodies, and individuals. In 2024, it recorded 112.91 billion yuan in welfare income and 140.87 billion yuan in welfare expenditures. Major corporate donors include AstraZeneca, Merck Sharp & Dohme (Asia), Pfizer Investment, and China National Pharmaceutical Group. Donations are made to specific programs including patient assistance projects, medical equipment donations, and grassroots healthcare capacity building.
2. Government Grants and Subsidies: The foundation receives government funding as its initial registered capital (原始基金数额为人民币800万元) was sourced from fiscal allocations (财政拨款). The foundation is under the supervision of the National Health Commission and registered with the Ministry of Civil Affairs, which implies ongoing government support.
3. Investment Income on Endowment Assets: Per its charter, the foundation generates investment income from managing its charitable endowment assets. The foundation states it pursues 'lawful, safe, and effective preservation and appreciation' of its fund assets.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

The China Primary Health Care Foundation is a national public fundraising charitable foundation that operates patient assistance programs delivering free or subsidized medications to low-income patients with serious illnesses, runs grassroots physician training and rural healthcare talent development projects, funds medical research through joint special funds with hospitals and device makers, and supports primary healthcare capacity building across rural and community institutions in China. It also publishes the China Primary Health Care Journal and supports TCM cultural communication and disease awareness campaigns.

Product overview

China Primary Health Care Foundation operates as a comprehensive public welfare platform offering multiple charitable programs focused on primary healthcare. The portfolio includes patient assistance programs covering oncology, hemophilia, and rare diseases; grassroots healthcare capacity building through the Tongxin General Practitioner program; regional healthcare assistance via the Dongfang Care program; internet+ healthcare development; and traditional Chinese medicine cultural exchange. The foundation also publishes the professional journal 'Chinese Primary Health Care' and manages specialized funds including the Universal Healthcare Public Welfare Fund and the Capital Health Development Research Mindray Joint Special Fund. The organization functions as a platform-plus-programs architecture rather than a unified technology product, coordinating medical assistance, research support, and healthcare system strengthening across China.

Differentiator

Problem solved

Functional benefit

Brands

• 通用环球公益专项基金: 专项基金围绕'医疗卫生强基工程''医疗援助与帮扶''医康养相结合应对人口老龄化'三大领域开展系列公益项目和活动
• 同心全科医生特岗人才公益项目
• 东方关爱公益项目
• 爱心惠民公益项目
• 新燕公益项目
• 首都卫生发展科研专项迈瑞联合专项

Products and services

• Patient Assistance Programs (患者援助项目) A category of charitable assistance programs that provide free or subsidized expensive medications to low-income patients with serious illnesses such as cancer. Programs are co-funded by the foundation and pharmaceutical manufacturer donors and delivered through partner hospitals.
• Tongxin General Practitioner Special Post Talent Program (同心全科医生特岗人才公益项目) A program that recruits, trains, and places general practitioners into special-post positions at rural and grassroots healthcare institutions, addressing physician shortages in underserved areas of China.
• Dongfang Care Public Welfare Program (东方关爱公益项目) A charitable program providing healthcare support and care services to beneficiaries.
• TCM Cultural Communication Public Welfare Program (中医药文化传播公益项目) A program promoting traditional Chinese medicine (TCM) cultural communication and public awareness of TCM practices.
• Internet+ Medical Development Public Welfare Program (互联网+医疗发展公益项目) A digital platform program supporting telemedicine services and online continuing medical education for rural and grassroots healthcare institutions in China.
• Shen Ze Medical Assistance Engineering Program (深泽医疗帮扶工程公益项目) A program providing equipment donations, training, and capacity-building support to village clinics and grassroots healthcare institutions in underserved areas.
• Xie Ai Tong Xing Public Welfare Program (携爱同行公益项目) A foundation charitable program providing healthcare assistance to beneficiaries.
• Xin Yan Public Welfare Program (新燕公益项目)

Quantifiable outcome

• 2024 annual public welfare income reached 112.91 billion yuan; cumulative welfare scale over 500 billion yuan in the past decade
• +5 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record, tiered major and core.

• 农工党广西区委 (NPG Guangxi Committee)majorStrategic or Co-development Partner · 1 July 2026In July 2026, the foundation partnered with the NPG Guangxi Committee to donate relief supplies (30,000 kg rice, 5,000 kg noodles) to flood-affected residents of Hengzhou City, Guangxi, following Typhoon Meisak's devastation.
• 民政部 / 国家民委 / 中国慈善联合会 / 黑龙江省政府coreStrategic or Co-development Partner · 1 January 2026The foundation participated as a partner in the '善行边疆' (Charity Along the Border) initiative organized by the Ministry of Civil Affairs and the State Ethnic Affairs Commission. In January 2026, the foundation signed a '健康塔河' elderly care project with the Tahe County Charity Federation in Heilongjiang. This is a three-year, 10-province border region poverty alleviation program.
• 通用技术环球医疗集团有限公司 (环球医疗)coreStrategic or Co-development Partner · 1 August 2025In August 2025, the foundation co-established the '通用环球公益专项基金' with 环球医疗 (a state-owned enterprise under China General Technology Group). The fund focuses on three areas: 医疗卫生强基工程 (grassroots healthcare strengthening), 医疗援助与帮扶 (medical assistance), and 医康养结合 (medical-elderly care integration). The partnership also launched the '十百千' public welfare plan including '点亮心光' (eye care, targeting 100 free cataract surgeries) and '星火强基' (grassroots doctor training targeting 1,000 doctors). 环球医疗 has cumulatively donated approximately 6,000,000 yuan.
• 北京市卫生健康委 / 北京市医药卫生科技促进中心 / 深圳迈瑞生物医疗电子股份有限公司coreStrategic or Co-development Partner · 1 April 2024In April 2024, the foundation partnered with the Beijing Municipal Health Commission, the Beijing Medical and Health Science and Technology Promotion Center, and Mindray (深圳迈瑞) to establish the '首都卫生发展科研专项迈瑞联合专项'. The foundation serves as the fundraising agent. The program funds innovation in laboratory testing, ultrasound, and critical care, supporting clinical research that serves economic development and public health.
• 国家传染病医学中心 / 复旦大学附属华山医院 (Zhang Wenhong)majorStrategic or Co-development Partner · 10 March 2021The 蓝农公益项目 was initiated by Professor Zhang Wenhong (Director of the National Center for Infectious Diseases, Head of Infection Department at Huashan Hospital, Fudan University) in Kunming, Yunnan in December 2020, and established at the foundation in March 2021.
• 全国人大常委会 / 农工党中央 / 曾益新院士coreStrategic or Co-development Partner · 1 October 2014The '同心全科医生特岗人才公益项目' was co-founded in October 2014 with the National People's Congress Standing Committee Vice Chairman 陈竺 (also NPG Central Committee Chairman) and CAS Academician 曾益新. The project addresses the '下不去、留不住' (unable to attract, unable to retain) challenge for medical professionals in grassroots settings.
• 山东中医药大学附属眼科医院coreStrategic or Co-development PartnerThe Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine provides the core medical team for the '点亮心光·环球医疗防盲复明公益行' project in Nimu County, Tibet (June 2026). The hospital provided surgical teams for 100 free cataract surgeries and hosted a local Tibetan ophthalmologist (伦珠加措) for one year of training in phacoemulsification surgery.
• AstraZeneca UK Limited / 阿斯利康医药（上海）有限公司 / 阿斯利康制药有限公司coreStrategic or Co-development PartnerAstraZeneca is a major pharmaceutical donor to the foundation. It supports multiple patient assistance programs: '因爱飞凡-肿瘤免疫治疗患者援助项目' (lung cancer immunotherapy, 371.7 million yuan in material donations in June 2026) and '沃悦新生患者援助项目'. AstraZeneca provides oncology medications for patient assistance distribution through the foundation's pharmacy network.
• Merck Sharp & Dohme (Asia) Ltd. / 默沙东（中国）投资有限公司coreStrategic or Co-development PartnerMerck Sharp & Dohme (MSD Asia) is a major pharmaceutical donor. In June 2026, MSD donated 888,326,584.32 yuan to the '生命之钥-肿瘤免疫治疗患者援助项目' (Key to Life oncology immunotherapy patient assistance) and 1,300,000 yuan to the '维爱不凡-VHL患者援助项目' (rare disease), totaling 14,104,625.96 yuan in cash donations plus 497,132.82 yuan in other donations.
• Pfizer Investment Co., Ltd. / 辉瑞投资有限公司coreStrategic or Co-development PartnerPfizer supports the '泰泽守护-患者援助项目' providing free talazoparib (泰泽纳/Talzenu) for metastatic castration-resistant prostate cancer (mCRPC) patients with HRR gene mutations. In June 2026, Pfizer donated 1,878,022.5 yuan + 186,246.9 yuan to the program and 2,021,172 yuan to the '择美同行患者援助项目'.
• 神州细胞工程有限公司majorStrategic or Co-development Partner神州细胞 donated 5,000,000 yuan to the '因你同行-血友病患者援助项目' in June 2026, supporting hemophilia patient assistance.
• 北京援藏指挥部 (Beijing Aid-Tibet Command)majorStrategic or Co-development PartnerThe Beijing Aid-Tibet Command is a co-organizer of the '点亮心光·环球医疗防盲复明公益行' project in Nimu County, Tibet, supporting the foundation's eye care initiative in high-altitude border regions.
• 中国医学科学院北京协和医院coreStrategic or Co-development PartnerThe foundation and Beijing Union Medical College Hospital jointly established the 罕见病公益项目 (Rare Disease Public Welfare Project) in December 2016, based on the hospital's national rare disease research platform (十三五国家科技支撑计划).
• 首都医科大学附属北京佑安医院coreStrategic or Co-development PartnerThe 佑安医学发展公益项目 was co-established with Beijing You'an Hospital (affiliated with Capital Medical University) on July 31, 2006, focusing on liver disease and AIDS prevention, research, and patient assistance.
• 中国农工民主党中央委员会 (NPG Central Committee)coreStrategic or Co-development PartnerThe foundation is organized and led by the Chinese Peasants' and Workers' Democratic Party (NPG), which serves as its founding organization (主办单位). The NPG provides political oversight and organizational support, and the foundation conducts public welfare activities under NPG leadership. The foundation also carries out joint disaster relief and public welfare activities with various NPG provincial committees.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• China Charity Federation: State-affiliated national umbrella organization for Chinese charities under the Ministry of Civil Affairs. Broader scope than the subject foundation but directly comparable in government affiliation and donor mobilization capabilities.

Direct peers

• Chinese Red Cross Foundation: National-level public fundraising foundation under the Red Cross Society of China, comparable in scale and 4A-rated status. Operates similar patient assistance, disaster relief, and humanitarian grant programs with comparable government oversight structure and donor mix.
• Amity Foundation: One of China's largest NGOs with healthcare, education, and social welfare programs. Comparable in operating as a national public fundraising organization with diverse corporate and international donor base.
• Lifeline Express Foundation (中华健康快车基金会): Specialized healthcare-focused public fundraising foundation operating mobile eye-care trains and cataract surgery programs. Closely comparable in grassroots healthcare capacity building and patient assistance delivery model.
• China Foundation for Poverty Alleviation: Major national public fundraising foundation with multi-billion RMB annual fundraising and similarly diverse corporate donor base. Highly comparable in operating scale, healthcare-adjacent poverty alleviation programs, and partnership model with enterprises.
• China Youth Development Foundation: Major national public fundraising foundation with similar governance structure and corporate donor mix. Operates some healthcare-adjacent programs (e.g., Hope Project health initiatives) and comparable fundraising scale.
• Soong Ching Ling Foundation: National-level public foundation with comparable 4A status and donor network. Operates maternal-child health, medical assistance, and education programs with similar pharma and enterprise donor partnerships.
• One Foundation (壹基金): High-profile Chinese public fundraising foundation focused on disaster relief, child welfare, and healthcare. Comparable operating model with enterprise partnership funds and similar regulatory standing under Ministry of Civil Affairs.
• China Women Development Foundation: National-level public fundraising foundation with comparable 4A rating and similar enterprise partnership fund structure. Operates overlapping health (maternal/child health, cancer assistance) and welfare programs.

Emerging players

• Shanghai United Foundation: Smaller but rapidly growing public fundraising foundation with stronger digital fundraising capabilities and emerging focus on healthcare and education. Representative of more digitally-native competition that may pressure traditional foundations on donor engagement.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E4%B8%AD%E5%9B%BD%E5%88%9D%E7%BA%A7%E5%8D%AB%E7%94%9F%E4%BF%9D%E5%81%A5%E5%9F%BA%E9%87%91%E4%BC%9A

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 中国初级卫生保健基金会